Valeant Pharmaceuticals International Liabilities:

13.90B for March 31, 2013
View Full Chart

Valeant Pharmaceuticals International Liabilities Chart

    Valeant Pharmaceuticals International Historical Liabilities Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 13.90B
    Dec. 31, 2012 14.23B
    Sept. 30, 2012 10.36B
    June 30, 2012 10.32B
    March 31, 2012 9.543B
    Dec. 31, 2011 9.178B
    Sept. 30, 2011 7.804B
    June 30, 2011 7.162B
    March 31, 2011 6.979B
    Dec. 31, 2010 5.884B
    Sept. 30, 2010 5.786B
    June 30, 2010 669.04M
    March 31, 2010 660.73M
    Dec. 31, 2009 704.92M
    Sept. 30, 2009 731.05M
    June 30, 2009 804.24M
    March 31, 2009 380.09M
    Dec. 31, 2008 421.97M
    Sept. 30, 2008 337.08M
    June 30, 2008 456.45M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Total Liabilities

    Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

    Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

    Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

    Simply, liabilities are the part of a company's assets that it has yet to repay back.
    Learn More

    Get data for

    VRX Liabilities Benchmarks

    Companies
    Actavis 10.57B
    Mylan 9.014B
    Warner Chilcott 4.818B

    VRX Liabilities Rankings

    Overall 36th percentile
    5068 of 8002
    Sector 9th percentile
    620 of 684 in Healthcare
    Industry 8th percentile
    62 of 68 in Drug Manufacturers - Specialty & Generic

    VRX Liabilities Range, Past 5 Years

    Minimum 337.07M Sep 2008
    Maximum 14.23B Dec 2012
    Average 5.316B